---
figid: PMC10041595__10.1177_15330338231161141-fig5
pmcid: PMC10041595
image_filename: 10.1177_15330338231161141-fig5.jpg
figure_link: /pmc/articles/PMC10041595/figure/fig5-15330338231161141/
number: Figure 5
figure_title: ''
caption: A diagram of NRF1 modulation of ROS homeostasis in breast cancer. The figure
  shows that NRF1 enhances EMT and anoikis resistance in breast cancer by regulating
  ROS homeostasis. In normal mammary epithelial cells, NRF1 overexpression increases
  ROS level and ATP production by activating the OXPHOS pathway, and consequently
  promotes EMT and anoikis resistance, furthermore NRF1 overexpression promotes the
  expression of ROS scavenging enzymes SOX2 and GPX1. Additionally, exogenous ROS
  can stimulates the expression of NRF1 and ROS scavenger enzymes to reduce ROS levels
  and thus inhibit EMT. NRF1 knockdown impairs the redox homeostasis in tumor cells
  by interrupting OXPHOS pathway and decrease the expression of ROS scavenging enzymes,
  thus promote MET.
article_title: NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer
  by Modulating ROS Homeostasis.
citation: Linjuan Sun, et al. Technol Cancer Res Treat. 2023;22:15330338231161141.
year: '2023'

doi: 10.1177/15330338231161141
journal_title: Technology in Cancer Research & Treatment
journal_nlm_ta: Technol Cancer Res Treat
publisher_name: SAGE Publications

keywords:
- NRF1
- breast cancer
- EMT
- anoikis
- OXPHOS
- ROS

---
